| Mar 26 | Mar 25 | Mar 23 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 131.00K | $ 144.00K | $ 370.00K | $ 1.50M | $ 0.00 |
| Gross Profit | $ 131.00K | $ 139.00K | $ 370.00K | $ 1.50M | $ 0.00 |
| Operating Income | $ -11.22M | $ -12.62M | $ -17.73M | $ -11.48M | $ -16.83M |
| EBITDA | $ -13.57M | $ -2.21M | $ -16.96M | $ -11.30M | $ -13.98M |
| Net Income | $ -13.84M | $ -2.49M | $ -17.26M | $ -11.45M | $ -16.83M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.02M | $ 11.31M | $ 16.01M | $ 28.68M | $ 37.36M |
| Total Assets | $ 7.39M | $ 14.65M | $ 20.31M | $ 33.30M | $ 39.92M |
| Total Debt | $ 447.00K | $ 942.00K | $ 1.80M | $ 2.18M | $ 0.00 |
| Net Debt | $ -4.58M | $ -10.37M | $ -13.50M | $ -26.49M | $ -37.36M |
| Total Liabilities | $ 8.48M | $ 4.16M | $ 4.98M | $ 3.09M | $ 721.00K |
| Stockholders' Equity | $ -1.10M | $ 10.49M | $ 15.33M | $ 30.21M | $ 39.20M |
| Cash Flow | |||||
| Free Cash Flow | $ -10.83M | $ -9.47M | $ -12.80M | $ -8.86M | $ -13.73M |
| Operating Cash Flow | $ -10.83M | $ -9.46M | $ -12.41M | $ -8.45M | $ -13.32M |
| Investing Cash Flow | $ 94.00K | $ 9.03M | $ -966.00K | $ -409.00K | $ -393.00K |
| Financing Cash Flow | $ 4.45M | $ 8.85M | $ 0.00 | $ 205.00K | $ 23.84M |
VivoSim Labs Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.